Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
Gelteq Limited - Ordinary Shares (GELS)
Company Research
Source: GlobeNewswire
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products, announces its largest U.S. customer, Healthy Extracts (OTCQB:HYEX), has increased its initial purchase order of Gelteq collagen and Mynus sugar blocker gels by 50%, citing high demand and popularity of the products. Healthy Extracts’ platform acquires, develops, patents, markets, and distributes plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market. This growing partnership supports Gelteq’s strategic push into the U.S. market following the recent hiring of Adam Bendell as the Company’s U.S. President and the establishment of a U.S.-based office. Production of Healthy Extracts’ order is underway, with shipment expecte
Show less
Read more
Impact Snapshot
Event Time:
GELS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GELS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GELS alerts
High impacting Gelteq Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
GELS
News
- Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology [Yahoo! Finance]Yahoo! Finance
- Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel TechnologyGlobeNewswire
- Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug [Yahoo! Finance]Yahoo! Finance
- Gelteq Receives FDA Approval of its Suitability Petition for New Animal DrugGlobeNewswire
- Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor ConferenceGlobeNewswire
GELS
Sec Filings
- 11/15/24 - Form 20-F
- 10/31/24 - Form NT
- 10/30/24 - Form 6-K
- GELS's page on the SEC website